We have located links that may give you full text access.
Journal Article
Review
Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis.
Clinical Nephrology 1991
The effects of cyclosporin A (CyA, Sandimmun) therapy in various types of primary glomerular diseases are discussed. In membranous nephropathy, the data strongly support a positive effect in this disorder, but there have been no control trials thus far to indicate the risk-benefit ratio, the need for adjunctive therapy such as steroids, or what to expect in terms of time to response or duration of response. The risk of nephrotoxicity needs to be more precisely quantitated both from a functional and pathological perspective. Proper prospective controlled trials are needed to establish the safety and efficacy of CyA in this disease. In both IgA and membranoproliferative glomerulonephritis, the data are more sparse. Although isolated studies have suggested a benefit in both these categories, the risks are also evident and more careful pilot studies are indicated before any further conclusions can be drawn as regards the use of this agent in these disorders.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app